In other studies, S glycoprotein-specific T cell responses were also greater after vaccination in previously SARS-CoV-2-infected participants than those who were infection-naïve [44, 45], and it is possible that vaccination boosted CD4+ T cell responses to the S glycoprotein that were below the threshold of detection [46, 47]. This evidence concerns the gene CD4 and infection.